Two Sigma Securities’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,200
Closed -$52.2K 2875
2022
Q4
$52.2K Buy
+11,200
New +$55.2K ﹤0.01% 2156
2021
Q4
Sell
-24,900
Closed -$1.02M 1724
2021
Q3
$1.02M Buy
24,900
+16,900
+211% +$613K 0.03% 493
2021
Q2
$288K Buy
+8,000
New +$295K 0.01% 1010

Other funds holding GDRX

Two Sigma Securities's GDRX Position: Q1 2026 in Review

Two Sigma Securities increased its GoodRx Holdings (GDRX) stake by 70% in Q1 2026, buying an estimated $52.2K and bringing the position to 53,980 shares worth $106K. The position accounts for 0.01% of the portfolio, ranked #1164.

Two Sigma Securities first reported a position in GDRX in Q4 2021 and has held it in 8 quarters since. The position peaked at $354K in Q4 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Two Sigma Securities held 53,980 shares of GoodRx Holdings worth $106K as of Q1 2026.
  • Two Sigma Securities bought 22,241 GoodRx Holdings shares in Q1 2026, an estimated $52.2K.
  • GoodRx Holdings made up 0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1164 holding.
  • Two Sigma Securities first reported a position in GoodRx Holdings in Q4 2021 and has held it in 8 quarters since.
  • Two Sigma Securities's GoodRx Holdings position peaked at $354K in Q4 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.